Stock UniverseDerived research view · source repositories remain read-only

Bausch Health Companies Inc. (BHC)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
32.15
Global Rank
1646
Market Cap
2.20B
Latest Close
5.37
RS Composite
-17.57% · G#2520

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-4.96%
3M
-0.19%
6M
-23.83%
1Y
15.73%
3Y
-34.59%
5Y
-83.30%
10Y
-81.12%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.84M · 30-day average: 2.00M · Max drawdown over stored range: -87.43%

Research Snapshot

Relative Strength vs SPX

RS Composite-17.57%
20D RS-6.92%
60D RS-10.08%
120D RS-30.39%
Global RS Rank2520 · 24.89% percentile
Watch+Speculative RS Rank1557 · 25.75% percentile
Group ScopeWatch+Speculative
Primary RS Rank273 · 40.39% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank202 / 701
Primary Percentile71.33
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-04-3010.53Bn/a587.00M-1.21B-3.222.13B720.00M1.41B375Mn/a5.57%-11.47%20.23%13.39%1.30B19.88B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-3.22-1.7x$28.100.2x$3.761.4x$5.680.9x

Shares Diluted: 375M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue843481248757962510266
Revenue Growth (YoY)5.07%-3.676%7.792%9.912%6.66%
Gross Profit60405760619868437253
Operating Income17081484162118742192
Free Cash Flow1157-94681712601003
Free Cash Flow Per Share3.224-2.6132.2393.4242.675
EPS (Diluted) GAAP-2.641404-0.621546-1.622362-0.130.42
EPS Growth
EPS Non-GAAP
Gross Margin71.615%70.901%70.778%71.096%70.651%
Operating Margin20.251%18.267%18.511%19.47%21.352%
Profit Margin-11.24%-2.77%-6.76%-0.478%1.529%
Free Cash Flow Margin13.718%-11.645%9.33%13.091%9.77%
Shares Outstanding (Diluted)358.9362364.9368375
Shares Change (YoY)1.099%0.864%0.801%0.85%1.902%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-302.52Bn/a-950.00M-37.64%-1.42B-56.38%-3.82372.80M1.30B19.88Bprocessed
2025 Q42026-02-192.80Bn/a474.00M16.95%-112.00M-4.01%-0.30377.70M1.31B20.59Bprocessed
2025 Q32025-10-302.68Bn/a619.00M23.09%179.00M6.68%0.48375.50M1.31B20.46Bprocessed
2025 Q22025-07-312.53Bn/a444.00M17.55%148.00M5.85%0.40373.10M1.73B20.86Bprocessed
2025 Q12025-05-012.26Bn/a276.00M12.22%-58.00M-2.57%-0.16369.60M1.13B21.23Bprocessed
2024 Q42025-02-202.56Bn/a558.00M21.81%93.00M3.63%0.25368.90M1.18B18.94Bprocessed
2024 Q32024-10-312.51Bn/a318.00M12.67%-85.00M-3.39%-0.23368.40M719.00M21.05Bprocessed
2024 Q22024-08-012.40Bn/a389.00M16.19%10.00M0.42%0.03370.20M595.00M21.21Bprocessed
2024 Q12024-05-022.15Bn/a281.00M13.05%-64.00M-2.97%-0.17366.80M733.00M21.54Bprocessed
2023 Q42024-02-222.41Bn/a362.00M15.03%-39.00M-1.62%-0.11366.10M947.00M21.94Bprocessed
2023 Q32023-11-022.24Bn/a14.00M0.63%-378.00M-16.89%-1.03365.40M760.00M21.89Bprocessed
2023 Q22023-08-032.17Bn/a412.00M19.01%26.00M1.20%0.07367.10M579.00M20.11Bprocessed
2023 Q12023-05-041.94Bn/a175.00M9.00%-201.00M-10.34%-0.55363.30M518.00M20.21Bprocessed
2022 Q42023-02-232.19Bn/a-236.00M-10.76%-410.00M-18.70%-1.15356.90M564.00M20.33Bprocessed
2022 Q32022-11-032.05Bn/a244.00M11.93%399.00M19.50%1.10363.40M486.00M20.80Bprocessed
2022 Q22022-08-091.97Bn/a161.00M8.19%-145.00M-7.37%-0.40362.20M659.00M21.66Bprocessed
2022 Q12022-05-101.92Bn/a285.00M14.86%-69.00M-3.60%-0.19360.80M1.25B23.17Bprocessed
2021 Q42022-02-232.20Bn/a367.00M16.71%69.00M3.14%0.19360.10M582.00M22.65Bprocessed
2021 Q32021-11-022.11Bn/a574.00M27.19%188.00M8.91%0.52364.00M690.00M22.36Bprocessed
2021 Q22021-08-032.10Bn/a-270.00M-12.86%-595.00M-28.33%-1.66359.10M642.00M23.44Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.